Mr. Alexander A. Fitzpatrick's most recent trade in ARS Pharmaceuticals Inc was a trade of 3,355 Common Stock done at an average price of $10 . Disclosure was reported to the exchange on June 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ARS Pharma Inc | Mr. Alexander A. Fitzpatrick, J.D. | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 12 Jun 2026 | 3,355 | 90,910 | - | 10 | 33,550 | Common Stock |
| ARS Pharma Inc | Mr. Alexander A. Fitzpatrick, J.D. | Chief Legal Officer | 02 Jan 2026 | 240,000 | 240,000 | - | - | Stock option (right to buy) | ||
| ARS Pharma Inc | Mr. Alexander A. Fitzpatrick, J.D. | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 14.10 per share. | 20 May 2025 | 102,969 | 89,613 | - | 14.1 | 1,451,513 | Common Stock |
| ARS Pharma Inc | Mr. Alexander A. Fitzpatrick, J.D. | Chief Legal Officer | 20 May 2025 | 100,000 | 200,000 | - | - | Stock Option (Right to Buy) | ||
| ARS Pharma Inc | Mr. Alexander A. Fitzpatrick, J.D. | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.58 per share. | 20 May 2025 | 100,000 | 192,582 | - | 5.6 | 558,000 | Common Stock |
| ARS Pharma Inc | Mr. Alexander A. Fitzpatrick, J.D. | Chief Legal Officer | 02 Jan 2025 | 152,300 | 152,300 | - | - | Stock option (right to buy) | ||
| ARS Pharma Inc | Mr. Alexander A. Fitzpatrick | Chief Legal Officer | 02 Jan 2024 | 300,000 | 300,000 | - | - | Stock option (right to buy) | ||
| ARS Pharma Inc | Mr. Alexander A. Fitzpatrick | Chief Legal Officer | Purchase of securities on an exchange or from another person at price $ 3.78 per share. | 28 Sep 2023 | 46,258 | 89,227 | - | 3.8 | 174,994 | - |
| ARS Pharma Inc | Mr. Alexander A. Fitzpatrick | Chief Legal Officer | Purchase of securities on an exchange or from another person at price $ 3.62 per share. | 28 Sep 2023 | 40,000 | 42,969 | - | 3.6 | 144,960 | - |
| ARS Pharma Inc | Mr. Alexander A. Fitzpatrick | Chief Legal Officer | 03 Jan 2023 | 700,000 | 700,000 | - | - | Stock option (right to buy) |